Skip to main
ASPI
ASPI logo

ASPI Stock Forecast & Price Target

ASPI Analyst Ratings

Based on 1 analyst ratings
Strong Buy
Strong Buy 100%
Buy 0%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

ASP Isotopes Inc is poised for growth due to the successful application of its laser-based quantum enrichment technology, which has been validated through the enrichment of ytterbium-176, a precursor to similar processes for uranium-235. This technological validation increases confidence in the company's ability to produce high-assay low-enriched uranium (HALEU) to meet the demands of the advanced nuclear fuel sector. Furthermore, the company operates in a favorable market environment, as it benefits from attractive pricing for natural gas in South Africa, which could potentially lower production costs and enhance profit margins.

Bears say

The financial outlook for ASP Isotopes Inc is negatively impacted by significant delays in achieving operational milestones, resulting in challenges with cash flow and sustainability. Additionally, the company's reliance on outdated infrastructure and a vulnerable power grid has led to inadequate electricity generation and recurring blackouts, further complicating the path to commercial viability. Compounding these issues, the rising demand and costs of natural gas, due to depletion of supplies, adds an additional layer of uncertainty regarding future operational expenses and profitability.

ASPI has been analyzed by 1 analysts, with a consensus rating of Strong Buy. 100% of analysts recommend a Strong Buy, 0% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of ASP Isotopes Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About ASP Isotopes Inc (ASPI) Forecast

Analysts have given ASPI a Strong Buy based on their latest research and market trends.

According to 1 analysts, ASPI has a Strong Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

ASP Isotopes Inc (ASPI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.